Vancouver, Canada

Steven Michial Ansell

USPTO Granted Patents = 26 

 

 

Average Co-Inventor Count = 2.4

ph-index = 17

Forward Citations = 1,244(Granted Patents)


Company Filing History:


Years Active: 1998-2024

Loading Chart...
Loading Chart...
Loading Chart...
26 patents (USPTO):Explore Patents

Title: Steven Michial Ansell – Innovator in Lipid Nanoparticle Technology

Introduction

Steven Michial Ansell is a prominent inventor based in Vancouver, Canada, recognized for his significant contributions to the field of pharmaceuticals, particularly in lipid nanoparticle formulations. With an impressive portfolio of 26 patents, Ansell has established himself as a key figure in the development of innovative therapeutic delivery systems.

Latest Patents

Among his recent patents, one focuses on "Lipids for use in lipid nanoparticle formulations," which details compounds that aid in the delivery of therapeutic agents through lipid nanoparticles. These compounds comprise specific structures, including their pharmaceutically acceptable salts or stereoisomers. In another important patent, Ansell explores "Carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids." This patent presents compounds with unique configurations that enhance the capabilities of lipid nanoparticles for efficient nucleic acid delivery.

Career Highlights

Steven Michial Ansell has lent his expertise to several leading companies in the biotechnology sector. He has worked with Acuitas Therapeutics, Inc., a firm known for its advancements in lipid nanotechnology, as well as Inex Pharmaceuticals Corporation, which is focused on innovative drug delivery solutions. His work in these organizations has been pivotal in pushing the boundaries of therapeutic applications and improving patient outcomes.

Collaborations

Throughout his career, Ansell has collaborated with distinguished professionals, including Xinyao Du and Michael J. Hope. These partnerships have fostered innovative approaches to research and development, further enhancing the efficacy of his contributions to lipid nanoparticle technologies.

Conclusion

Steven Michial Ansell’s work exemplifies the spirit of innovation in the biotechnology industry. His extensive patent portfolio and collaboration with top companies and peers underline his commitment to advancing therapeutic delivery methods, ultimately benefitting the healthcare sector and improving the lives of patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…